Australia markets closed

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4850-0.0050 (-1.02%)
At close: 04:00PM EDT
0.5024 +0.02 (+3.59%)
After hours: 07:39PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
5,233
Operating expenses
Research development
7,174
7,174
15,837
8,549
6,914
Selling general and administrative
5,721
5,721
7,138
6,105
6,106
Total operating expenses
12,895
12,895
22,975
12,813
12,844
Operating income or loss
-12,895
-12,895
-22,975
-12,813
-7,611
Total other income/expenses net
-
-
-8,851
44.693
258.551
Income before tax
-12,543
-12,543
-31,608
-12,768
-7,352
Income from continuing operations
-12,543
-12,543
-31,608
-12,768
-7,352
Net income
-12,543
-12,543
-31,608
-12,768
-7,352
Net income available to common shareholders
-12,543
-12,543
-31,608
-12,768
-7,749
Basic EPS
-6.59
-3.84
-14.88
-7.72
-12.50
Diluted EPS
-6.59
-3.84
-14.88
-7.72
-12.50
Basic average shares
2,842
3,265
2,125
1,655
623.144
Diluted average shares
2,842
3,265
2,125
1,655
623.144